"Torcetrapib" Example Sentences
1. Torcetrapib was once thought to be a promising drug for reducing cholesterol levels.
2. The clinical trial for torcetrapib was prematurely stopped due to adverse cardiovascular events.
3. Despite initial excitement, torcetrapib failed to live up to its expectations.
4. Scientists are still trying to understand why torcetrapib had such negative effects on the heart.
5. The failure of torcetrapib was a major setback for the pharmaceutical industry.
6. Researchers are continuing to investigate the potential risks of torcetrapib.
7. Many people were disappointed when torcetrapib failed to become a successful medication.
8. The disappointment surrounding torcetrapib prompted a renewed search for alternative treatments.
9. The development of torcetrapib ultimately did not lead to any life-saving breakthroughs.
10. The history of torcetrapib offers lessons for drug development and clinical trials.
11. The risks associated with torcetrapib highlighted the need for rigorous testing before new drugs are introduced to the market.
12. The negative results from torcetrapib's clinical trial have had a lasting impact on the field of cardiovascular research.
13. The scientific community is still grappling with the implications of torcetrapib's failure.
14. The potential benefits of torcetrapib did not outweigh the potential risks.
15. The story of torcetrapib serves as a cautionary tale for the pharmaceutical industry.
16. The development and ultimate demise of torcetrapib were closely watched by many in the medical community.
17. Despite promising early results, torcetrapib ultimately failed to deliver on its intended purpose.
18. The use of torcetrapib was associated with a higher risk of mortality in clinical trials.
19. The search for a viable alternative to torcetrapib continues today.
20. The failure of torcetrapib was a major blow for patients and doctors alike.
21. The discovery of torcetrapib was initially met with great enthusiasm.
22. The clinical trial for torcetrapib was one of the largest and most expensive in history.
23. The story of torcetrapib highlights the challenges of drug development and testing.
24. The negative outcomes from torcetrapib's clinical trial have had a lasting impact on the pharmaceutical industry.
25. Despite its hype, torcetrapib ultimately proved to be ineffective and even harmful.
26. The potential benefits of torcetrapib were outweighed by the potential risks.
27. The development of torcetrapib was a major scientific undertaking, but it ultimately failed to deliver on its promises.
28. The story of torcetrapib is a reminder of how difficult it can be to predict the outcomes of medical interventions.
29. The failure of torcetrapib was a disappointment for many who had high hopes for its potential benefits.
30. The legacy of torcetrapib reminds us of the importance of cautious and rigorous experimentation in medical research.
Common Phases
Torcetrapib is a cholesterol ester transfer protein inhibitor;
Torcetrapib reduces LDL cholesterol and raises HDL cholesterol;
Torcetrapib is being researched as a potential treatment for cardiovascular disease;
Torcetrapib was discontinued from development due to safety concerns.